| Market Cap | 152M 134M 126M 115M 215M 14.58B 217M 1.51B 586M 7.42B 570M 558M 24.14B | P/E 2024 |
-3.79x | P/E 2025 | -1.91x |
|---|---|---|---|---|---|
| Enterprise Value | 129M 113M 107M 97.37M 182M 12.36B 184M 1.28B 496M 6.29B 483M 473M 20.46B | EV / Sales 2024 |
0.19x | EV / Sales 2025 | 0.3x |
| Free-Float |
99.05% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Depomed Inc
| 1 day | -9.45% |
| Director | Title | Age | Since |
|---|---|---|---|
Ravi Yadavar
BRD | Director/Board Member | 26 | 15/06/2026 |
Punit Patel
BRD | Director/Board Member | - | 15/06/2026 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -9.45% | +3.54% | - | - | 152M | ||
| +2.68% | +3.87% | +58.22% | +114.68% | 1,026B | ||
| +0.56% | +1.27% | +53.29% | +68.65% | 649B | ||
| +0.02% | +0.99% | +19.10% | +73.58% | 468B | ||
| +0.06% | +0.25% | +37.03% | +45.71% | 352B | ||
| +1.16% | +4.10% | +21.99% | +29.39% | 271B | ||
| -0.24% | +2.18% | +10.14% | +12.26% | 256B | ||
| -0.01% | +7.89% | +41.57% | +51.68% | 220B | ||
| -1.11% | +1.36% | +30.85% | +99.56% | 188B | ||
| +0.30% | -7.19% | -32.43% | -60.56% | 170B | ||
| Average | -0.87% | +1.26% | +26.64% | +48.33% | 399.9B | |
| Weighted average by Cap. | +0.12% | +1.26% | +37.30% | +67.68% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 125M 110M 104M 94.54M 177M 12B 178M 1.24B 482M 6.1B 469M 459M 19.87B | 119M 104M 98.44M 89.81M 168M 11.4B 169M 1.18B 458M 5.8B 446M 436M 18.87B |
| Net income | -21.58M -18.98M -17.89M -16.33M -30.53M -2.07B -30.77M -215M -83.21M -1.05B -81.03M -79.27M -3.43B | -30.38M -26.72M -25.19M -22.98M -42.97M -2.92B -43.31M -302M -117M -1.48B -114M -112M -4.83B |
| Net Debt | -59.79M -52.59M -49.58M -45.23M -84.59M -5.74B -85.25M -595M -231M -2.92B -224M -220M -9.51B | -23.15M -20.36M -19.2M -17.51M -32.75M -2.22B -33.01M -230M -89.27M -1.13B -86.93M -85.04M -3.68B |
Employees
-
Sector
Pharmaceuticals
















